1,2-didodecanoylglycerol has been researched along with Infections, Plasmodium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, H; Jain, SA; Joshi, MD; Mathur, D; Pathak, S; Patravale, VB; Prabhu, PS; Sharma, S; Soni, U | 1 |
| Awale, M; Jain, SA; Pathak, S; Patravale, VB; Sharma, S; Vanage, G | 1 |
2 other study(ies) available for 1,2-didodecanoylglycerol and Infections, Plasmodium
| Article | Year |
|---|---|
Parasite impairment by targeting Plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers.
Topics: Animals; Antimalarials; Cell Line; Diglycerides; Drug Carriers; Drug Delivery Systems; Endocytosis; Erythrocytes; Fluorescence; Glycerol; Kinetics; Lipids; Malaria; Male; Mice; Nanostructures; Parasites; Particle Size; Plasmodium; Static Electricity | 2014 |
Teratogenicity of Artemether-Clindamycin Nanostructured Lipid Carriers in Rats.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Clindamycin; Diglycerides; Drug Carriers; Female; Malaria; Male; Maternal-Fetal Exchange; Mice; Monoglycerides; Nanostructures; Pregnancy; Rats, Sprague-Dawley | 2016 |